Hong Kong
· Delayed Price · Currency is HKD RemeGen Statistics
Total Valuation
RemeGen has a market cap or net worth of HKD 15.52 billion. The enterprise value is 17.23 billion.
| Market Cap | 15.52B |
| Enterprise Value | 17.23B |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RemeGen has 537.91 million shares outstanding. The number of shares has decreased by -1.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 537.91M |
| Shares Change (YoY) | -1.12% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 11.44% |
| Owned by Institutions (%) | 38.97% |
| Float | 340.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.18 |
| PB Ratio | 3.76 |
| P/TBV Ratio | 6.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.03 |
| EV / Sales | 9.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -50.56% and return on invested capital (ROIC) is -18.86%.
| Return on Equity (ROE) | -50.56% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -18.86% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 504,975 |
| Profits Per Employee | -432,105 |
| Employee Count | 3,615 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.25% in the last 52 weeks. The beta is 0.45, so RemeGen's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -21.25% |
| 50-Day Moving Average | 14.50 |
| 200-Day Moving Average | 17.30 |
| Relative Strength Index (RSI) | 62.04 |
| Average Volume (20 Days) | 3,837,440 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RemeGen had revenue of HKD 1.83 billion and -1.56 billion in losses. Loss per share was -2.91.
| Revenue | 1.83B |
| Gross Profit | 1.83B |
| Operating Income | -1.54B |
| Pretax Income | -1.56B |
| Net Income | -1.56B |
| EBITDA | -1.36B |
| EBIT | -1.54B |
| Loss Per Share | -2.91 |
Balance Sheet
The company has 984.51 million in cash and 2.70 billion in debt, giving a net cash position of -1.71 billion or -3.18 per share.
| Cash & Cash Equivalents | 984.51M |
| Total Debt | 2.70B |
| Net Cash | -1.71B |
| Net Cash Per Share | -3.18 |
| Equity (Book Value) | 2.52B |
| Book Value Per Share | 4.68 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -84.43% and -85.57%.
| Gross Margin | 100.00% |
| Operating Margin | -84.43% |
| Pretax Margin | -85.57% |
| Profit Margin | -85.57% |
| EBITDA Margin | -74.40% |
| EBIT Margin | -84.43% |
| FCF Margin | n/a |
Dividends & Yields
RemeGen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.12% |
| Shareholder Yield | 1.12% |
| Earnings Yield | -10.07% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |